The TGA gave low-dose cannabis sales without prescription the green light in February. But no product has jumped through all the regulatory hoops to market yet.
Paxlovid is one potential COVID drug for use at home. The idea is these can potentially be prescribed at the first sign of infection to prevent serious illness and death.
Regulators are currently reviewing the safety and efficacy data of the Pfizer vaccine for five to 11 year olds before deciding whether to approve its use in this age group.
In short, it’s because the texts do not constitute ‘advertising’ – a good reason for the legislation to be revisited and widened.
Side-effects for this unproven and potentially dangerous treatment range from vomiting and diarrhoea to seizures and a coma.
The Moderna vaccine has been provisionally approved by the Therapeutic Goods Administration for use in Australia, with one million doses due in the second half of September, which will go to pharmacies.
Whipping cream canisters contain nitrous oxide, which some people use to get high. But going ahead with a proposal before the TGA to ban them altogether would be an overreaction.
One study found antibody levels were significantly higher in people who received one dose of AstraZeneca then a Pfizer booster dose.
A serious event such as a blood clot could be caused by an underlying medical condition, a medication the person was taking at the time, or some other factor unrelated to the vaccine.
COVID-19 has resulted in higher than normal levels of medicine shortages. Here’s what to do if your local pharmacy is out of stock.
Australia is still aiming to start vaccinating high-risk groups from March. Why the delay?
A few simple pointers can help you spot a quality mask from a dud.
Amyl nitrite, known as poppers, can now legally be sold in pharmacies. But don’t expect to see it stocked any time soon. No product has yet passed Australia’s manufacturing and testing process.
It’s not just women who are the losers following the latest TGA announcement. People with all types of medical devices need better regulatory protection.
The proposed Australian ban of some types of breast implants is too little, too late. It also reveals regulatory failures that need to be fixed if Australian consumers are to be protected.
Advances in technology mean it’s now possible to 3D print everything from prosthetic limbs to skin, bones and organs.
Who should be legally responsible when 3D printed devices fail? Proposed changes to the Therapeutic Goods Administration’s regulatory framework have the potential to settle that question.
It’s misleading to say that withdrawing codeine-containing products from sale without a prescription will reduce codeine use.
The claim there is no evidence painkillers combined with lower doses of codeine are more effective in treating pain, is misleading. As are others in this debate.
The Australian drugs regulator is overhauling the health claims made by suppliers of complementary medicines, including homeopathic therapies. And some curious options are up for discussion.
Would you trust a complementary medicine described as “vermifuge”, “vulnerary” or “emmenagogue”? That’s what new labelling proposes and not everyone’s happy about it.
Hundreds of women have complained of adverse reactions from transvaginal mesh implants.
Regulatory bodies approved some medical devices to treat pelvic organ prolapse and urinary incontinence before having data to prove their safety and efficacy.
Some of the notable additions to the PBS include drugs to treat eye and HIV infections, cystic fibrosis, multiple sclerosis, and cancer.
An independent expert provides his pick of the most notable drugs added to the PBS on May 1, 2017.
How do you really know if vitamin and mineral supplements really ‘help your heart’ or ‘boost your mood’?
If the Therapeutic Goods Administration implements new proposals to regulate complementary medicines, you can be more confident they actually do what they say on the packet.